top of page

NCCN 2022 Breast Cancer Congress

NCCN
2/11/22, 1:00 PM
America/Chicago UTC -5

Description

10:00 – 10:05 AM
Opening Remarks
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

 

10:05 – 10:35 AM
Genetic/Familial Risk Assessment for Breast Cancer: Testing Considerations and Controversies
Allison W. Kurian, MD, MSc
Stanford Cancer Institute

 

10:40 – 11:40 AM
Impact of the Pandemic on Breast Cancer Screening
Sarah M. Friedewald, MD
Sonya Bhole, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Sharon Walenga, BS, RT(R)(M)
Advocate Aurora Healthcare

 

11:40 AM – 12:00 PM
Break

 

12:00 – 1:15 PM
Locoregional Management of Non-Metastatic Breast Cancer with SABCS Updates

  • Surgical Management of Non-Metastatic Breast Cancer with SABCS Updates
    A. Marilyn Leitch, MD
    UT Southwestern Simmons Comprehensive Cancer Center
  • Radiation Therapy for Non-Metastatic Breast Cancer with SABCS Updates
    Meena S. Moran, MD
    Yale Cancer Center/Smilow Cancer Hospital

1:15 – 2:00 PM
Break

 

2:00 – 3:00 PM
Neoadjuvant and Adjuvant Treatment for Breast Cancer with SABCS Updates*

  • Neoadjuvant and Adjuvant Treatment for HER2-Negative Breast Cancer with SABCS Updates
    Ami N. Shah, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Neoadjuvant and Adjuvant Treatment for HER2-Positive Breast Cancer with SABCS Updates
    Karen Lisa Smith, MD, MPH
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

3:05 – 4:05 PM
Management of Metastatic Breast Cancer with SABCS Updates*

  • Management of HER2-Negative Metastatic Breast Cancer with SABCS Updates
    William J. Gradishar, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Management of HER2-Positive Metastatic Breast Cancer with SABCS Updates
    Hope S. Rugo, MD
    UCSF Helen Diller Family Comprehensive Cancer Center

4:05 – 4:25 PM
Break

 

4:25 – 5:25 PM
Managing Pain and Neuropathy in Breast Cancer Survivors*
Maryam B. Lustberg, MD, MPH
Kathryn D. Mason, FNP
Annette P. Hood, PharmD, BCACP
Yale Cancer Center/Smilow Cancer Hospital

 

5:25 – 5:30 PM
Closing Remarks

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Opening Remarks, Genetic/Familial Risk Assessment for Breast Cancer: Testing Considerations and Controversies, Impact of the Pandemic on Breast Cancer Screening, Locoregional Management of Non-Metastatic Breast Cancer with SABCS Updates, Neoadjuvant and Adjuvant Treatment for Breast Cancer with SABCS Updates, Management of Metastatic Breast Cancer with SABCS Updates, Managing Pain and Neuropathy in Breast Cancer Survivors, Closing Remarks

Inglês

Description

Speakers

William J. Gradishar, Allison W. Kurian, Sarah M. Friedewald, Sonya Bhole, A. Marilyn Leitch, Meena S. Moran, Ami N. Shah, Karen Lisa Smith, Hope S. Rugo, Maryam B. Lustberg, Kathryn D. Mason, Annette P. Hood

Speakers

Link to the Event

Banner to the Event

NCCN 2022 Breast Cancer Congress
Link to Event
Banner
Registro
bottom of page